* FTSEurofirst 300 up 0.9 pct
* Roche, AstraZeneca boost market
* Eyes on Greek talks, German inflation data
By Francesco Canepa
LONDON, June 1 (Reuters) - European shares kicked off June on a positive note on Monday, helped by a rise in pharma stocks, although main indexes were still stuck in their recent range as uncertainty persisted over Greece’s future.
AstraZeneca and Roche, both up 2 percent, led a rise in the healthcare sector after each published a positive update on one of their anti-cancer drugs.
They helped boost the pan-European FTSEurofirst 300 index , which was up 0.9 percent at 1,599.98 points after shedding 2 percent the previous week.
Athens and its euro zone and International Monetary Fund (IMF) creditors have been locked in talks for months on a cash-for-reforms agreement. Athens faces a payment to the IMF on June 5 as well as the expiration of its bailout programme on June 30.
“We were short at the end of last week but we’re neutral now,” Markus Huber, senior trader at Peregrine & Black, said.
“Greece may not get a deal (this) week but they will probably make the (IMF) payment.”
Investors were awaiting May manufacturing data from major euro zone countries and the currency bloc as a whole between 0745 GMT and 0800 GMT. Monthly German inflation data, which helped spark a selloff in bonds in May, was due at 1200 GMT.
Shares in Vestas Wind fell 2.1 percent, the top fallers on the FTSEurofirst 300, after Citigroup analysts downgraded the stock to “sell” from “hold”.
“Vestas’ growth profile does not appear as compelling as the cap goods sector,” the analysts wrote in a note.
Europe bourses in 2015: link.reuters.com/pap87v
Asset performance in 2015: link.reuters.com/gap87v
Today’s European research round-up (Editing by Dominic Evans)